U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
VUDALIMAB
USAN   INN  
Official Name English
IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) AND ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY, BISPECIFIC
Common Name English
Vudalimab [WHO-DD]
Common Name English
PD-1 X CTLA-4 DUAL CHECKPOINT INHIBITOR XMAB20717
Common Name English
IMMUNOGLOBULIN, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB20717 SINGLE-CHAIN VARIABLE FRAGMENT VL-LINKER-VH) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), (260
Common Name English
ANTI-PD-1/ANTI-CTLA-4 XMAB20717
Common Name English
XMAB20717
Code English
VUDALIMAB [USAN]
Common Name English
vudalimab [INN]
Common Name English
ANTI-PD1/CTLA4 BISPECIFIC ANTIBODY XMAB20717
Common Name English
XMAB-20717
Common Name English
Code System Code Type Description
NCI_THESAURUS
C150463
Created by admin on Sat Dec 16 14:30:03 GMT 2023 , Edited by admin on Sat Dec 16 14:30:03 GMT 2023
PRIMARY
FDA UNII
4I9I5X3Z6N
Created by admin on Sat Dec 16 14:30:03 GMT 2023 , Edited by admin on Sat Dec 16 14:30:03 GMT 2023
PRIMARY
CAS
2329669-72-7
Created by admin on Sat Dec 16 14:30:03 GMT 2023 , Edited by admin on Sat Dec 16 14:30:03 GMT 2023
PRIMARY
CAS
2303884-42-4
Created by admin on Sat Dec 16 14:30:03 GMT 2023 , Edited by admin on Sat Dec 16 14:30:03 GMT 2023
NO STRUCTURE GIVEN
USAN
JK-26
Created by admin on Sat Dec 16 14:30:03 GMT 2023 , Edited by admin on Sat Dec 16 14:30:03 GMT 2023
PRIMARY
INN
11464
Created by admin on Sat Dec 16 14:30:03 GMT 2023 , Edited by admin on Sat Dec 16 14:30:03 GMT 2023
PRIMARY